|EORTC Risk Tables for Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer|
The provided software implements the EORTC Scoring System and Risk Tables for Stage Ta T1 Bladder Cancer as published in the paper:
Sylvester RJ, van der Meijden APM, Oosterlinck W, Witjes JA, Bouffioux C, Denis L, Newling DWW, and Kurth KH. Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials. European Urology 49: 466 - 477, 2006.
They allow the user to estimate the probability of recurrence and progression in patients with stage Ta T1 bladder cancer based on six different factors:
(Versions are available for Windows, iPhone/iPad and Android phones/tablets)
Window software programmed by Richard Sylvester, EORTC Headquarters.
iPhone/iPad and Android versions have been developed in cooperation with Cambridge Laboratories, a division of Alliance Pharmaceuticals Ltd.